News

UK Survey Seeks Input from Dementia Patient Caregivers

Parkinson’s UK has opened a survey aimed at understanding the experiences of caregivers of people who have Lewy body dementia or Parkinson’s disease dementia. The survey seeks to shed light on the support caregivers receive, and caregivers’ and patients’ experiences with the health and social care system in…

Dancing the Tango May Reduce Fall Risk, Help With Balance

Dancing the tango may help people with Parkinson’s disease maintain balance and avoid falling, according to new research from Florida State University (FSU). “Argentine tango involves specific dance techniques that decrease fall risk and are generally not taught in other dances or activities,” Shani Peter, a third-year medical student…

Facial Recognition Program IDs Parkinson’s Patients as Older, Expressionless

Differences in the facial appearance and emotional expressions of people with Parkinson’s disease and  healthy adults were evident to a facial recognition software program, researchers in Japan reported. The program’s algorithm consistently overestimated the age of the nearly 100 patients in this study by a few years, particularly for males, and perceived…

Collaboration Tackles Sleep Problems in Parkinson’s

Cambridge Sleep Sciences and Parkinson’s Concierge have entered an agreement to tackle sleep problems in Parkinson’s disease. Sleep problems such as difficulty falling asleep, daytime sleepiness, and troubled dreams are among the most common non-motor symptoms of Parkinson’s disease. Sleep also can be indirectly affected by other…

Foundation Hosting Virtual, Contactless Moving Day Events

The Parkinson’s Foundation has announced that this year’s Moving Day walk season will include virtual and contactless events. Moving Day, which is the Foundation’s signature fundraising event, aims to increase awareness about Parkinson’s disease, as well as raise money that will fund research and provide expert care for…

Type 2 Diabetes Linked to Increased Risk of Parkinson’s

People with type 2 diabetes may have an increased risk of developing Parkinson’s disease and for experiencing faster Parkinson’s progression, according to a large-scale analysis of past research. The study, “Type 2 Diabetes as a Determinant of Parkinson’s Disease Risk and Progression,” was published in the…

Interim Trial Data Hints at Efficacy of ANVS401

ANVS401, an investigational therapy for neurodegenerative diseases being developed by Annovis Bio, improved the speed and coordination of people with Parkinson’s disease in a Phase 2a clinical trial, an interim analysis suggests. “The results from this interim analysis are very encouraging. This brings us one step closer to…